Modeling of the pharmacokinetic/pharmacodynamic interaction between irbesartan and hydrochlorothiazide in normotensive subjects-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Modeling of the pharmacokinetic/pharmacodynamic interaction between irbesartan and hydrochlorothiazide in normotensive subjects

Published:2015-02-04 Issue:4 Volume:36 Page:216-231
ISSN:0142-2782
Container-title:Biopharmaceutics & Drug Disposition
language:en
Short-container-title:Biopharm. Drug Dispos.

Author:

Hedaya Mohsen A.¹,Helmy Sally A.²³

Affiliation:

1. Department of Pharmaceutics, Faculty of Pharmacy; Kuwait University; Kuwait

2. Department of Pharmaceutics, Faculty of Pharmacy; Damanhour University; Damanhour Egypt

3. Department of Clinical and Hospital Pharmacy, Faculty of Pharmacy; Taibah University; Al-Madinah Al-Munawarah Kingdom of Saudi Arabia

Publisher

Wiley

Subject

Pharmacology (medical),Pharmaceutical Science,Pharmacology,General Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/bdd.1935/fullpdf

Reference60 articles.

1. Using fixed-dose combination therapies to achieve blood pressure goals;Chrysant;Clin Drug Investig,2008

2. Combination therapy with ACE inhibitors/angiotensin II receptor antagonists and diuretics in hypertension;Waeber;Expert Rev Cardiovasc Ther,2003

3. A review of irbesartan in antihypertensive therapy: comparison with other antihypertensive agents;Waeber;Curr Ther Res,2001

4. Cardiac and renal protective effects of irbesartan via peroxisome proliferator-activated receptor γ-hepatocyte growth factor pathway independent of angiotensin II Type 1a receptor blockade in mouse model of salt-sensitive hypertension;Kusunoki;J Am Heart Assoc,2013

5. Assessment of the drug-drug interactions between fimasartan and hydrochlorothiazide in healthy volunteers;Jeon;J Cardiovasc Pharmacol,2012

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Analytical quality by design approach to develop an eco-friendly RP-HPLC method for estimation of irbesartan in chitosan polymeric nanoparticles: forced degradation studies and assessment of in vitro release mathematical modelling;RSC Advances;2024

2. Overview of the pharmacokinetics and pharmacodynamics of URAT1 inhibitors for the treatment of hyperuricemia and gout;Expert Opinion on Drug Metabolism & Toxicology;2023-11-25

3. Oral Formulation Based on Irbesartan Nanocrystals Improve Drug Solubility, Absorbability, and Efficacy;Pharmaceutics;2022-02-10

4. Influence of release rate, dose and co-administration on pharmacokinetics, pharmacodynamics and PK-PD relationship of tanshinone IIA and tanshinol;European Journal of Pharmaceutical Sciences;2022-01

5. Validation of population pharmacokinetic models: a comparison of internal and external validation approaches for hydrochlorothiazide;Xenobiotica;2021-12-02

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3